Alcresta Therapeutics, Inc.

Biotechnology · Financial Services
2 legal entities

Facts

as of Nov 17, 2026

By continuing to use this site, you consent to our use of cookies to personalize your experience and to analyze website traffic. Learn more in our privacy policy.

Legal name
Alcresta Therapeutics, Inc.
Headquarters
Newton, United States
Founded
2011
Employees
201-500estimated range
Legal entities
2 in 1 countries
Register numbers
NAME alcresta therapeutics inc · EIN 452729951
Official records
SEC CIK 1673510
Website
alcresta.com

These are the key facts about Alcresta Therapeutics, Inc. on Alion as of Nov 17, 2026. Alcresta Therapeutics, Inc. is headquartered in Newton, United States. It was founded in 2011. It has raised $75.9M in 4 funding rounds. The latest round is Venture - Series Unknown of $10M, announced in 2020.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Alcresta Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Newton United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$75.9MTotal raised
Venture - Series UnknownLatest round
4Rounds and grants
Money by yearUSD, rounds and grants
2020$10M1 record
2019$5M1 record
2017$10M1 record
2016$50.9M1 record
Sources: funding announcements, grant and company registers

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

Jan 232026
News · YahooFinance
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced the publication of real-wor…
Oct 6, 20252025
News · YahooFinance
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today announced expansion of the company
Sources: the outlets named on each headline, each story once